Jeff Schaffnit Shares Sanofi’s Patient Advocacy Voices Series with Caroline Kruse
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared on LinkedIn:
”Many people living with immune thrombocytopenia (ITP) face a critical hurdle: getting a proper diagnosis.
Caroline Kruse, President and CEO of the Platelet Disorder Support Association – PDSA, and other experts know this challenge well.
Despite the organization’s over 25 years of educating, supporting and advocating for the ITP community, diagnosis remains one of the most critical unmet needs for people living with ITP and other rare blood disorders.
My colleague Eric Racine, PharmD, MBA had the opportunity to speak with Caroline as part of Sanofi’s Patient Advocacy Voices series.
We stand proudly with PDSA and the ITP community in our commitment to raising awareness and supporting people living with ITP.
Watch the full conversation here.”
Stay updated with Hemostasis Today.
-
Dec 11, 2025, 16:18Caitlin Raymond’s Commentary on Artificial Intelligence in Transfusion Medicine is Out!
-
Dec 11, 2025, 15:20Giles Platford on Takeda’s 5 Year Deal with WFH for The Humanitarian Aid Program!
-
Dec 11, 2025, 15:05Kristof Vercruysse on ”First in Human” Presented at ASH25
-
Dec 11, 2025, 12:50Harlan Krumholz on Half-Life of Evidence and The Need for Real-Time Trials
-
Dec 11, 2025, 12:34Riitta Lassila on LMWH Benefits in COVID19
-
Dec 11, 2025, 12:30A Neutrophil-Mesangial Cell Axis Promotes Glomerular Injury in Lupus Nephritis
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
-
Dec 11, 2025, 12:12Zoey Becker: CSL Proves Efficacy of Hemophilia B Gene Therapy Hemgenix Holds up After 5 Years